Metadata from OpenAlexLast checked: May 20, 2026

Cancer Imaging — Journal Profile & Submission Links

BioMed Central · ISSN-L 1470-7330

Cancer Imaging publishes articles in oncology.

Listed metrics: Q1, open access, APC $2890, OpenAlex 2-year citedness 4.55.

Authors checking fit can use the scope note and the official links on this profile.

→ Check whether your manuscript fits this journal, free

This page provides a source-backed journal profile and links to official submission resources. Journal instructions can change. Always verify article types, formatting, fees, ethics requirements, and submission rules on the official journal website before submitting.

Official links

Publisher
BioMed Central
Publisher country
United Kingdom
Open access
Yes
Listed in DOAJ
Yes
APC (USD)
$2,890
Works count
2033
Cited-by count
39594
OpenAlex 2-year mean citedness
4.55
Quartile
Q1

The journal's own scope statement

The text below is the catalog scope statement for this journal.

Keywords: ct, mri, pet, malignant tumours, multimodal imaging, imaging biomarkers Subjects: Medical physics. Medical radiology. Nuclear medicine, Neoplasms. Tumors. Oncology. Including cancer and carcinogens

Catalog source: merged. This is not a copy of the publisher's author instructions.

For review time and acceptance rate, see the journal's official author guidelines. www.cancerimagingjournal.com/authors/instructions

General pre-submission checks for medical manuscripts

Generic checklist only — not journal-specific requirements.

  • Confirm scope fit and intended article type on the official journal site.
  • Abstract structure matches the journal's current requirements.
  • Ethics approval and trial registration statements are complete.
  • Informed consent and patient privacy statements are in place.
  • Reporting guideline compliance (e.g. CONSORT, STROBE, PRISMA) as applicable.
  • Reference style and citation limits per official guidelines.
  • Figures and tables meet resolution, labeling, and count limits.
  • Cover letter addresses novelty, fit, and required declarations.
  • Conflicts of interest statement included.
  • Funding statement included.
  • Data availability statement included when required.

FAQ